Log In
BCIQ
Print this Print this
 

S42909

  Manage Alerts
Collapse Summary General Information
Company Servier
Description NADPH oxidase inhibitor
Molecular Target NADPH oxidase
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationDermal ulcers
Indication DetailsTreat venous lower limb ulcers
Regulatory Designation
PartnerIlkos Therapeutics Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

09/27/2016

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today